Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
Shahar Shelly(Rambam Health Care Campus), Teerin Liewluck(Mayo Clinic in Arizona), Αναστασία Ζεκερίδου(Mayo Clinic), Marcus Vinícius Pinto(Mayo Clinic in Arizona), Felix E. Diehn(Mayo Clinic in Arizona), Margherita Milone(Ospedale Policlinico San Martino), James Triplett(Mayo Clinic in Arizona)
Cited by 116
Related Papers
Autoimmune Encephalitis Misdiagnosis in Adults
|JAMA Neurology|2022|278
Autoimmune glial fibrillary acidic protein astrocytopathy
|Current Opinion in Neurology|2019|241
Aquaporin-4 autoimmunity
|Neurology Neuroimmunology & Neuroinflammation|2015|202
Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year
|Journal of Neuroimmunology|2018|200
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses
|Clinical Infectious Diseases|2021|179